Effects of Caffeine on Women's Sexual Arousal

Status:

WITHDRAWN

Effects of Caffeine on Women's Sexual Arousal

Lead Sponsor:

University of Texas at Austin

Conditions:

Sexual Behavior

Eligibility:

FEMALE

18+ years

Phase:

Brief Summary

The key research question in this study is whether or not caffeine facilitates genital sexual arousal in women in the presence of an external erotic stimulus. Caffeine's impact on the human sexual res...

Eligibility Criteria

Inclusion

Women aged 18 or older
Heterosexual
Experiencing regular menstrual cycles (not more than 1 missed menstrual period in the past 6 months).
Currently involved in a stable, sexually active relationship.
Fluent in the English language.

Exclusion

Self-report of sexual aversion or distress; or of distress related to a history of unwanted or coercive sexual contact.
Perimenopausal or menopausal status, or \>1 missed menstrual period in the previous 6 months; or currently pregnant, breastfeeding, or having breastfed within the past 3 months; or clinically significant untreated renal or endocrine disease.
History of HIV infection or active, untreated pelvic, vaginal, or urinary tract infection including sexually transmitted diseases such as chlamydia, genital herpes, gonorrhea, or syphilis.
Previous major pelvic surgery that may have caused nerve damage, including hysterectomy, vulvectomy, circumcision, colostomy, cystostomy, or serious bladder, rectal, or abdominal surgery; or neurological impairment due to diabetes, stroke, pelvic nerve damage secondary to trauma, cancer treatments, myasthenia gravis, multiple sclerosis or spinal cord damage.
Self-report of an untreated psychosis (e.g., bipolar disorder or schizophrenia).
Women who do not use caffeine products regularly (i.e., on a daily basis).
Women receiving any of the following medications will be excluded from the study, as they have been shown to alter sexual function or arousal response: Dehydroepiandrosterone (DHEA), testosterone and other androgens, estrogens (except oral contraceptives), progesterone, tamoxifen, raloxifene, and other selective estrogen receptor modulators (SERMs), Beta blockers or other drugs that affect the autonomic nervous system and/or cardiovascular system, any approved or experimental medications or treatments used to enhance the sexual response (e.g., sildenafil), and antidepressants

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01242046

Last Update

May 27 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)